Mylan N.V. (MYL) Financial Statements (2024 and earlier)

Company Profile

Business Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY
HATFIELD, HERTFORDSHIRE, AL10 9UL
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments324572 359212230
Cash and cash equivalents324572 359212230
Restricted cash and investments116 1611
Receivables2,4412,429 2,5472,2772,367
Inventory, net of allowances, customer advances and progress billings2,7862,640 2,7642,7762,709
Inventory2,7862,640 2,7642,7762,709
Prepaid expense168162 154154132
Other current assets336311 284301311
Other undisclosed current assets409471 523545513
Total current assets:6,4656,601 6,6456,2656,262
Noncurrent Assets
Property, plant and equipment2,0382,067 2,1242,1462,151
Intangible assets, net (including goodwill)20,47920,374 21,21122,42422,563
Goodwill9,5239,327 9,3879,6939,608
Intangible assets, net (excluding goodwill)10,95611,047 11,82412,73112,956
Regulated entity, other noncurrent assets  57    
Deferred income tax assets749     
Other noncurrent assets425404 445429422
Deferred tax assets, net628553508
Other undisclosed noncurrent assets  645    
Total noncurrent assets:23,69123,545 24,40825,55225,644
TOTAL ASSETS:30,15530,146 31,05431,81731,907
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,5451,528 1,6651,6771,340
Taxes payable288254 15313923
Accounts payable1,2571,274 1,5111,5381,317
Other liabilities2,2282,213 2,3752,1332,114
Other undisclosed current liabilities3,1981,488 605751704
Total current liabilities:6,9715,228 4,6454,5604,158
Noncurrent Liabilities
Long-term debt and lease obligation9,15411,198 12,46112,59013,087
Long-term debt, excluding current maturities8,99411,198 12,46112,59013,087
Liabilities, other than long-term debt, including:8882 84254237
Deferred tax liabilities, net1,5571,6351,643
Deferred income tax liabilities1,542     
Liability for uncertainty in income taxes110101 756476
Liability, pension and other postretirement and postemployment benefits402406 383393390
Other liabilities901919 9281,1291,127
Operating lease, liability159     
Other undisclosed liabilities, other than long-term debt(2,868)(1,343) (2,859)(2,968)(3,000)
Other undisclosed noncurrent liabilities2,1972,375 2,4012,5102,534
Total noncurrent liabilities:11,43813,655 14,94515,35415,857
Total liabilities:18,40918,883 19,59019,91420,015
Equity
Equity, attributable to parent11,74611,263 11,463(2,402)(2,598)
Common stock66 6  
Treasury stock, value(1,000)(1,000) (1,000)(1,000)(1,000)
Additional paid in capital8,6738,658 8,638  
Accumulated other comprehensive loss(2,025)(2,454) (2,191)(1,402)(1,599)
Retained earnings6,0926,052 6,011  
Other undisclosed equity     14,30414,490
Total equity:11,74611,263 11,46311,90311,892
TOTAL LIABILITIES AND EQUITY:30,15530,146 31,05431,81731,907

Income Statement (P&L) ($ in millions)

9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
Revenues2,7312,619(8,309)2,9622,8522,496
Cost of revenue
(Cost of Goods and Services Sold)
(1,706)(1,713) (1,889)(1,919)(1,690)
Gross profit:1,026906 1,072933805
Operating expenses(892)(721) (749)(837)(781)
Operating income:134185 3249624
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
2(34) (9)(16)(7)
Interest and debt expense(116)(120) (129)(131)(131)
Income (loss) from continuing operations before income taxes:2031 186(52)(115)
Income tax expense (benefit)19(10) 4(116)90
Income (loss) from continuing operations:3921 190(169)(25)
Income (loss) before gain (loss) on sale of properties:3921 190(169)(25)
Net income (loss) available to common stockholders, diluted:3921 190(169)(25)

Comprehensive Income ($ in millions)

9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
Net income (loss):3921 190(169)(25)
Other comprehensive income (loss)429(656) (650)169(266)
Comprehensive income (loss), net of tax, attributable to parent:468(636) (460)0(291)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: